Approximately 80% of clinical trials will face delays at some point in the trial process. Jason Gagner talked with ACT about how PurpleLab uses real-world data to better inform trials and improve their success rates.

Learn More About:

• Utilizing real-world data (RWD) to assist clinical trials achieve key milestones
• Employing a criteria specific geographic analysis of patient populations to expedite site feasibility assessments
• Understanding the impact of diversity, equity, and inclusion (DEI) in clinical trials on meeting trial objectives and timelines
• Integrating social determinants of health (SDOH) data to minimize patient dropout rates